Are you Dr. Hillson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 25 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1493 Cambridge St
Cambridge Health Alliance
Cambridge, MA 02139Phone+1 617-665-2300
Summary
- Dr. Jan Hillson, MD is a rheumatologist in Cambridge, Massachusetts. She is currently licensed to practice medicine in Washington.
Education & Training
University of WashingtonFellowship, Rheumatology, 1986 - 1989- University of WashingtonResidency, Internal Medicine, 1982 - 1983
- University of Washington [Boise]Residency, Internal Medicine, 1981 - 1982
- University of WashingtonInternship, Internal Medicine, 1980 - 1981
Stanford University School of MedicineClass of 1980
Certifications & Licensure
WA State Medical License 1981 - 2026- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Fellow American College of Rheumatology
Clinical Trials
- Efficacy and Safety Study of PEG-rIL-29 Plus Ribavirin to Treat Chronic Hepatitis C Virus Infection Start of enrollment: 2010 May 01
- Controlled Trial Evaluating Avacopan in C3 Glomerulopathy Start of enrollment: 2017 Sep 29
Publications & Presentations
PubMed
- 11 citationsFirst-in-human study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ALPN-101, a dual CD28/ICOS antagonist, in healthy adult subjectsJing Yang, Jason D. Lickliter, Jan Hillson, Gary Means, Russell J. Sanderson
Clinical and Translational Science. 2021-07-01 - 37 citationsEvaluation of the Safety and Efficacy of Avacopan, a C5a Receptor Inhibitor, in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Treated Concomi...Peter A. Merkel, David Jayne, Chao Wang, Jan Hillson, Pirow Bekker
JMIR Research Protocols. 2020-04-07 - 19 citationsMolecular profiling of rheumatoid arthritis patients reveals an association between innate and adaptive cell populations and response to anti-tumor necrosis factor.Victor Farutin, Thomas Prod’homme, Kevin Mcconnell, Nathaniel Washburn, Patrick Halvey
Arthritis Research & Therapy. 2019-10-23
Press Mentions
Great Danes: Two Nordic Biotechs Name Their Chief Executives; Axel Hoos Bids Adieu to GlaxoSmithKline, Becomes CEO of Small Oncology PlayerJuly 9th, 2021- Eledon Pharmaceuticals Appoints Jan Hillson, M.D., to Its Board of DirectorsJuly 2nd, 2021
Alpine Immune Sciences (ALPN) Presents ALPN-101 Phase 1 Healthy Volunteer Study Data and Details of Upcoming Phase I/II BALANCE GVHD Study at ASHDecember 9th, 2019- Join now to see all
Grant Support
- Origin Of Rheumatoid FactorsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1990–1993
- Inducible Expression Of Semi-Synthetic Antibody GenesNational Institute Of Allergy And Infectious Diseases1986–1989
